$ASAP #Asarina Pharma Asarina Pharma (Hold, TP: SEK9.00) - Termination of PMDD development: Following yesterday’s announcement that the phase IIb study in PMDD had failed to meet its primary and secondary endpoints, Asarina Pharma has… https://t.co/kbDHA9p0Fb #equity #stocks